- Matuozzo, Daniela
- Talouarn, Estelle|||0000-0002-5016-0446
- Marchal, Astrid
- Zhang, Peng|||0000-0002-6129-567X
- Manry, Jeremy|||0000-0001-5998-2051
- Seeleuthner, Yoann|||0000-0002-1878-8567
- Zhang, Yu|||0000-0002-0332-0013
- Bolze, Alexandre|||0000-0001-7399-2766
- Chaldebas, Matthieu
- Milisavljevic, Baptiste
- Gervais, Adrian|||0000-0002-1083-5787
- Bastard, Paul|||0000-0002-5926-8437
- Asano, Takaki
- Bizien, Lucy|||0000-0001-9163-9122
- Barzaghi, Federica
- Abolhassani, Hassan|||0000-0002-4838-0407
- Abou Tayoun, Ahmad
- Aiuti, Alessandro|||0000-0002-5398-1717
- Alavi Darazam, Ilad
- Allende-Martinez, Luis M.
- Alonso-Arias, Rebeca
- Arias, Andrés Augusto|||0000-0002-9478-8403
- Aytekin, Gokhan
- Bergman, Peter
- Bondesan, Simone
- Bryceson, Yenan
- Bustos, Ingrid G.
- Cabrera-Marante, Oscar
- Carcel, Sheila
- Carrera, Paola
- Casari, Giorgio|||0000-0002-0115-8980
- Chaïbi, Khalil
- Colobrán Oriol, Roger|||0000-0002-5964-536X
- Condino-Neto, Antonio|||0000-0002-1069-3117
- Covill, Laura E.
- Delmonte, Ottavia M.
- El Zein, Loubna
- Flores, Carlos|||0000-0001-5352-069X
- Gregersen, Peter K.|||0000-0003-1613-1518
- Gut, Marta|||0000-0002-4063-7159
- Haerynck, Filomeen|||0000-0001-9161-7361
- Halwani, Rabih|||0000-0002-6516-7771
- Hancerli, Selda
- Hammarström, Lennart|||0000-0002-8635-9609
- Hatipoğlu, Nevin
- Karbuz, Adem
- Keles, Sevgi|||0000-0001-7344-8947
- Kyheng, Christèle
- Leon-Lopez, Rafael
- Franco, Jose Luis
- Mansouri, Davood
- Martínez Picado, Francisco Javier|||0000-0002-4916-2129
- Metin Akcan, Ozge
- Migeotte, Isabelle
- Morange, Pierre-Emmanuel|||0000-0002-9065-722X
- Morelle, Guillaume|||0000-0001-6511-1674
- Martín Nalda, Andrea|||0000-0002-1715-153X
- Novelli, Giuseppe|||0000-0002-7781-602X
- Novelli, Antonio
- Ozcelik, Tayfun|||0000-0001-5937-1082
- Palabiyik, Figen
- Pan-Hammarström, Qiang|||0000-0003-1990-8804
- Perez de Diego, Rebeca|||0000-0001-8426-8765
- Planas-Serra, Laura|||0000-0002-2586-0897
- Pleguezuelo, Daniel E.
- Prando, Carolina|||0000-0002-9570-9770
- Pujol, Aurora|||0000-0002-9606-0600
- Reyes, Luis Felipe|||0000-0003-1172-6539
- Rivière, Jacques G.|||0000-0003-1055-2063
- Rodriguez-Gallego, Carlos
- Rojas, Julian
- Rovere-Querini, Patrizia
- Schlüter, Agatha|||0000-0001-6732-1528
- Shahrooei, Mohammad
- Sobh, Ali
- Soler Palacín, Pere|||0000-0002-0346-5570
- Tandjaoui-Lambiotte redondo, Yacine|||0000-0003-1123-4788
- Tipu, Imran
- Tresoldi, Cristina
- Troya, Jesus
- van de Beek, Diederik|||0000-0002-4571-044X
- Zatz, Mayana|||0000-0003-3970-8025
- Zawadzki, Pawel
- Al-Muhsen, Saleh Zaid
- Alosaimi, Mohammed Faraj
- Alsohime, Fahad M.
- Baris-Feldman, Hagit|||0000-0003-4065-7560
- Butte, Manish J.
- Constantinescu, Stefan N.
- Cooper, Megan A.
- Dalgard, Clifton L.|||0000-0003-2025-8239
- Fellay, Jacques|||0000-0002-8240-939X
- Heath, James R.|||0000-0001-5356-4385
- Lau, Yu Lung|||0000-0002-4780-0289
- Lifton, Richard P.
- Maniatis, Tom|||0000-0002-2722-8633
- Mogensen, Trine H.
- von Bernuth, Horst
- Lermine, Alban
- Vidaud, Michel
- Boland, Anne|||0000-0001-8789-5676
- Deleuze, Jean-François
- Nussbaum, Robert
- Kahn-Kirby, Amanda
- Mentre, France
- Tubiana, Sarah
- Gorochov, Guy|||0000-0003-2097-9677
- Tubach, Florence
- Hausfater, Pierre|||0000-0002-7716-6354
- Meyts, Isabelle|||0000-0003-1214-0302
- Zhang, Shen-Ying|||0000-0002-9449-3672
- Puel, Anne|||0000-0003-2603-0323
- Notarangelo, Luigi|||0000-0002-8335-0262
- Boisson-Dupuis, Stephanie|||0000-0002-7115-116X
- Su, Helen C.|||0000-0002-5582-9110
- Boisson, Bertrand|||0000-0001-5240-3555
- Jouanguy, Emmanuelle|||0000-0002-7358-9157
- Casanova, Jean-Laurent|||0000-0002-7782-4169
- Zhang, Qian|||0000-0002-9040-3289
- Abel, Laurent|||0000-0001-7016-6493
- Cobat, Aurélie|||0000-0001-7209-6257
We previously reported that impaired type I IFN activity, due to inborn errors of TLR3- and TLR7-dependent type I interferon (IFN) immunity or to autoantibodies against type I IFN, account for 15-20% of cases of life-threatening COVID-19 in unvaccinated patients. Therefore, the determinants of life-threatening COVID-19 remain to be identified in ~ 80% of cases. We report here a genome-wide rare variant burden association analysis in 3269 unvaccinated patients with life-threatening COVID-19, and 1373 unvaccinated SARS-CoV-2-infected individuals without pneumonia. Among the 928 patients tested for autoantibodies against type I IFN, a quarter (234) were positive and were excluded. No gene reached genome-wide significance. Under a recessive model, the most significant gene with at-risk variants was TLR7, with an OR of 27.68 (95%CI 1.5-528.7, P = 1.1 × 10 -4) for biochemically loss-of-function (bLOF) variants. We replicated the enrichment in rare predicted LOF (pLOF) variants at 13 influenza susceptibility loci involved in TLR3-dependent type I IFN immunity (OR = 3.70[95%CI 1.3-8.2], P = 2.1 × 10 -4). This enrichment was further strengthened by (1) adding the recently reported TYK2 and TLR7 COVID-19 loci, particularly under a recessive model (OR = 19.65[95%CI 2.1-2635.4], P = 3.4 × 10 -3), and (2) considering as pLOF branchpoint variants with potentially strong impacts on splicing among the 15 loci (OR = 4.40[9%CI 2.3-8.4], P = 7.7 × 10 -8). Finally, the patients with pLOF/bLOF variants at these 15 loci were significantly younger (mean age [SD] = 43.3 [20.3] years) than the other patients (56.0 [17.3] years; P = 1.68 × 10 -5). Rare variants of TLR3- and TLR7-dependent type I IFN immunity genes can underlie life-threatening COVID-19, particularly with recessive inheritance, in patients under 60 years old. The online version contains supplementary material available at 10.1186/s13073-023-01173-8.